USFDA Probes Cancer Risk Linked to Novartis' Zolgensma, Nine Tumour Reports Recorded

Coverage, in order

1. 2d ago
   
   Medical Dialogues India obscure study observational

   USFDA Probes Cancer Risk Linked to Novartis' Zolgensma, Nine Tumour Reports Recorded

   Zurich : The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis' gene therapy Zolgensma. The Swiss drugmaker earlier in the day disclosed two cases in which tumours in children showed evidence…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.